What is Coherence Neuro?
Coherence Neuro operates at the critical nexus of neurotechnology, neurobiology, and machine learning, aiming to fundamentally alter the landscape of cancer treatment. The company challenges the status quo of conventional oncology—which often relies on invasive surgical, radiological, or chemical interventions—by proposing a more precise, technology-driven management model. By leveraging sophisticated data analytics and biological insights, Coherence seeks to transform cancer from a debilitating battle into a manageable condition, thereby significantly enhancing patient quality of life and long-term health outcomes.
How much funding has Coherence Neuro raised?
Coherence Neuro has raised a total of $10M across 1 funding round:
Seed
$10M
Seed (2025): $10M with participation from Artesian, Blackbird Ventures, Possible Ventures, XTAL Strategies, and SmartGateVC
Key Investors in Coherence Neuro
Artesian
A global alternative investment management firm that focuses on early-stage venture capital and high-growth technology sectors.
Blackbird Ventures
A prominent venture capital firm specializing in backing ambitious founders building world-changing technology companies.
Possible Ventures
An investment firm that supports early-stage startups focused on deep tech and scientific breakthroughs with global impact.
What's next for Coherence Neuro?
With this major strategic investment, Coherence Neuro is poised to scale its proprietary technology platform and expand its clinical research initiatives. The company's roadmap likely involves deepening its integration of machine learning algorithms to refine diagnostic and therapeutic precision. As it moves forward, the firm will focus on validating its neuro-oncology models in clinical settings, aiming to establish a new standard of care that prioritizes patient well-being alongside efficacy. This phase of growth will be critical in demonstrating the scalability of its technology to institutional partners and the broader medical community.
See full Coherence Neuro company page
